Provost TT, Maize JC, Ahmed AR, et al. Unusual subepidermal bullous diseases with immunologic features of bullous pemphigoid[J]. Arch Dermatol, 1979, 115(2): 156⁃160. DOI: 10.1001/archderm.1979.04010020002002.
Das D, Bandyopadhyay D. Juvenile pemphigoid nodularis: report of a rare case[J]. Indian Dermatol Online J, 2014, 5(2): 189⁃192. DOI: 10.4103/2229⁃5178.131101.
[4]
Mochizuki M, Fujine E, Tawada C, et al. Pemphigoid nodularis possibly induced by etanercept[J]. J Dermatol, 2013, 40(7): 578⁃579. DOI: 10.1111/1346⁃8138.12171.
[5]
Cliff S, Holden CA. Pemphigoid nodularis: a report of three cases and review of the literature[J]. Br J Dermatol,1997, 136(3): 398⁃401.
[6]
Powell AM, Albert S, Gratian MJ, et al. Pemphigoid nodularis (non⁃bullous): a clinicopathological study of five cases[J]. Br J Dermatol, 2002, 147(2): 343⁃349.
[7]
Brick KE, Weaver CH, Savica R, et al. A population⁃based study of the association between bullous pemphigoid and neurologic disorders[J]. J Am Acad Dermatol, 2014, 71(6): 1191⁃1197. DOI: 10.1016/j.jaad.2014.07.052.
[8]
Schachter M, Brieva JC, Jones JC, et al. Pemphigoid nodularis associated with autoantibodies to the NC16A domain of BP180 and a hyperproliferative integrin profile[J]. J Am Acad Dermatol, 2001, 45(5): 747⁃754. DOI: 10.1067/mjd.2001.116229.
[9]
Hurskainen T, Kokkonen N, Sormunen R, et al. Deletion of the major bullous pemphigoid epitope region of collagen XVII induces blistering, autoimmunization, and itching in mice[J]. J Invest Dermatol, 2015, 135(5): 1303⁃1310. DOI: 10.1038/jid.2014.443.